Small Intestinal Bacterial Overgrowth: A Prospective Registry

Launched by INDIANA UNIVERSITY · Mar 27, 2013

Keywords

ClinConnect Summary

Same as above

Gender

ALL

Eligibility criteria

• • 1.Study Subjects Inclusion Criteria i. All patients who are undergoing small bowel aspiration for suspected SIBO regardless etiology.
• • Exclusion Criteria i. Use of colon cleansing prep in the past 1 month ii. Treatment with antibiotics in the past 30 days (antibiotics are allowable for patients undergoing clinical indicated repeat aspiration to determine bacteria clearance) iii. Use of probiotics in the past 30 days iv. Contraindication for upper endoscopy for any reason v. Prisoners vi. Pregnant vii. Unable to give own informed consent
• • 2 Control Subjects Inclusion Criteria i. Patients who are undergoing double balloon enteroscopy or upper enteroscopy for another medical reason.
• • Exclusion Criteria i. Diagnosis of SIBO ii. Diagnosis of functional dyspepsia iii. Established risk factors for SIBO (ANY of the following)
• • 1. Connective tissue disorder (scleroderma, polymyositis, mixed connective tissue disease, or systemic lupus
• • 2. Resection of ileocecal valve for any reason
• • 3. Chronic intestinal pseudo-obstruction
• • 4. Small bowel blind limb, diverticulum or fistula
• • 5. Surgery with decreased gastric acid exposure for small bowel a. Gastric surgery with vagotomy (Bilroth I, Bilroth II, vagotomy/pyloroplasty) or gastric bypass iv. Use of colon cleansing prep in the past 1 month v. Use of antibiotics in the past 30 days vi. Use of probiotics in the past 30 days vii. Contraindication for upper endoscopy for any reason viii. Prisoners ix. Pregnant x. Unable to give own informed